Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
19.83
+0.01 (0.05%)
At close: Aug 21, 2026, 4:00 PM EDT
19.72
-0.11 (-0.57%)
Pre-market: Aug 24, 2026, 7:06 AM EDT

Avalo Therapeutics Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Guggenheim
Guggenheim
Buy
Reiterates
$50$48
BuyReiterates$50$48+142.06%Aug 7, 2026
BTIG
BTIG
Buy
Maintains
$58
BuyMaintains$58+192.49%Aug 7, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$35
BuyReiterates$35+76.50%Aug 7, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$35$30
BuyReiterates$35$30+51.29%Aug 7, 2026
Leerink Partners
Leerink Partners
Buy
Initiates
$38
BuyInitiates$38+91.63%Jul 6, 2026
TD Cowen
TD Cowen
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 11, 2026
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$36$39
BuyMaintains$36$39+96.67%May 15, 2026
Wedbush
Wedbush
Buy
Reiterates
$40$34
BuyReiterates$40$34+71.46%May 14, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.